Karyopharm Therapeutics reported $-42908000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbott ABT:US $ 2478M 434M
Amgen AMGN:US $ 2176M 324M
AstraZeneca AZN:LN 181.11B 36.36B
Astrazeneca AZN:US 2.2B 673M
Avrobio Inc AVRO:US $ -27774000 1.64M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Bristol Myers Squibb BMY:US $ 3197M 9M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Enanta Pharmaceuticals ENTA:US $ -32540000 1.31M
Epizyme EPZM:US $ -29806000 21.12M
GlaxoSmithKline GSK:LN 181.6B 5.9B
Johnson & Johnson JNJ:US $ 6941M 599M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Macrogenics MGNX:US $ -41808000 24.83M
Merk MRK:US $ 5711M 652M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Novartis NVS:US 3.32B 176M
Novartis NOVN:VX 3.32B 176M
Pfizer PFE:US $ 12099M 2104M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sangamo Biosciences SGMO:US $ -45734000 473K
Takeda 4502:JP 150.52B 152.13B
Tg Therapeutics TGTX:US $ -38941000 27.93M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Xencor XNCR:US $ -28000000 54.47M
YTE INCY:US $ 260.29M 132.62M